While the overall risk of secondary cancers after Kaposi sarcoma has declined in people with HIV/AIDS, clinicians should be aware that certain cancers are becoming increasingly common in the highly active antiretroviral therapy era compared with the pre-HAART era. READ MORE

Research in Review

Results argue against the inclusion of ifosfamide and etoposide to postoperative chemotherapy in patients with poorly responding osteosarcoma.

READ MORE

Researchers looked at patients diagnosed with non-metastatic soft-tissue sarcoma to determine how different factors correlated with survival. 

READ MORE